Disease Progression

Chen, S., Miravitlles, M., Rhee, C. K., Pavord, I. D., Jones, R., Carter, V., et al. (2022). Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. Int J Chron Obstruct Pulmon Dis, 17, 2187-2200. http://doi.org/10.2147/copd.s378649

View

Whittaker, H., Van Ganse, E., Dalon, F., Nolin, M., Marrant-Micallef, C., Pison, C., et al. (2022). Differences in severe exacerbations rates and healthcare utilisation in COPD populations in the UK and France. Bmj Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2021-001150

View

Aoki, Y., Cabrera, C. S., Ouwens, M., Bamberg, K., Nyström, J., Raz, I., et al. (2022). Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data. Plos One, 17, e0269970. http://doi.org/10.1371/journal.pone.0269970

View

Sansbury, L. B., Rothnie, K. J., Bains, C., Compton, C., Anley, G., & Ismaila, A. S. (2021). Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England. Int J Chron Obstruct Pulmon Dis, 16, 2591-2604. http://doi.org/10.2147/copd.s318969

View

Whittaker, H., Rubino, A., Mullerova, H., Morris, T., Varghese, P., Xu, Y., et al. (2022). Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study. Int J Chron Obstruct Pulmon Dis, 17, 427-437. http://doi.org/10.2147/copd.s346591

View